Finding early Indicators of Neurological Damage in Sickle Cell Disease

Finding early Indicators of Neurological Damage in Sickle Cell Disease - FIND

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35805

Enrollment

150

Registered

2012-02-01

Start date

2011-09-16

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sickle cell disease stroke

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Sickle cell disease Age 8-16 treated at AMC or Erasmus MC

Exclusion criteria

Exclusion criteria: Overt stroke Chronic blood transfusion scheme The presence of metal in the body Claustrofobia

Design outcomes

Primary

Measure	Time frame
Primary outcome is progression of brain infarcts on MRI.	—

Secondary

Measure	Time frame
Secondary outcome is diminished neurocognitive functioning.	—

Countries

Netherlands

Outcome results